Companies » Company Overview » Ankur Drugs & Pharma Ltd.
 
 
  • BSE: 531683
  • NSE: ANKURDRUGS
  • ISIN Code: INE238D01012
  • Sector: Health care
bse
3.93
0 (0.00%)
Open 3.70
Day High 4.02
Day Low 3.65
Previous Close 3.93
Volume 9225
52-Week high 4.02
52-Week low 0.00
P/E -
Mkt Cap.(Rs cr) 8
NSE

4.55
0 (0.00%)
Bse

3.93
0 (0.00%)
nse
4.55
0 (0.00%)
Open 4.55
Day High 4.70
Day Low 4.55
Previous Close 4.55
Volume 12111
52-Week high 4.70
52-Week low 0.00
P/E -
Mkt Cap.(Rs cr) 8

Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Company Information

Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of pharmaceuticals formulations. The company has three manufacturing units: two in Himachal Pradesh and one in Daman. Its business segment includes pharmaceutical formulations in the form of tablets, capsules, liquid orals, oral powder, dry syrups, ointments, insta use suspension, form fill and seal (FFS), liquid injectables and dry powder injectables. Its clients include Ranbaxy Laboratories Limited, Cipla Limited, Sandoz Private L... [More]

Key Fundamentals
Market Cap (Rs cr) 8
EPS - TTM (Rs)

[*S]

-
P/E Ratio (x)

[*S]

-
Face Value (Rs) 10
Latest Dividend (%) 22.50
Latest Dividend Date 21 Sep 2010
Dividend Yield (%) 0.00
Book Value / Share (Rs)

[*S]

-9.83
P/B Ratio (x)

[*S]

-0.40
[*C] Consolidated [*S] Standalone
STOCK STRENGTH
Today's Low/High
3.65
4.02
Week Low/High
0.00
4.02
Month Low/High
0.00
4.02
YEAR Low/High
0.00
4.02
All TIME Low/High
1.75
487.00
Peer Group
Company Last Change(%)
Combat Drugs 10.65 3.90
Twilight Litaka 3.47 -4.93
Sanjiv.Parant. 17.30 0.00
Advik Labs. 7.15 -4.79
Zenith Health 0.79 1.28
Sandu Pharma. 16.15 -0.62
Brawn Biotech 6.87 4.89
Returns
Period Ankur Drugs Sensex NIFTY
1 Week NA 2.63% 2.54%
1 Month NA 7.67% 7.80%
3 Month NA 8.45% 8.56%
6 Month NA 17.33% 17.73%
1 Year NA 41.06% 42.23%
3 Year -79.10% 83.52% 82.91%
Period Ankur Drugs Sensex NIFTY
1 Week NA 2.63% 2.54%
1 Month NA 7.67% 7.80%
3 Month NA 8.45% 8.56%
6 Month NA 17.33% 17.73%
1 Year NA 41.06% 42.23%
3 Year -75.86% 83.52% 82.91%
Financial Results
Particulars (Rs cr) Dec 2012 Dec 2011 %Chg
Net Sales 36.12 38.5 -6.18
Other Income 0.01 0.01 0
Total Income 36.13 38.51 -6.18
Total Expenses 37.64 45.92 -18.03
Operating Profit -1.51 -7.41 79.62
Net Profit -40.84 -36.62 -11.52
Equity Capital 19.34 19.34 -
SHAREHOLDING PATTERN
As on Mar 2013
Board of directors
Chairman & Managing Director : Purnandu Jain
Whole Time Executive Director : Girraj Vijayvargiya
Director : Dileep Shinde
Director : Clifton Zimmermann
Company Secretary : S C Rane
Director : Ramesh Batham
AUDITOR: M G Vashi & Co
IND NAME: Pharmaceuticals - Indian - Formulations
HOUSE NAME: Indian Private
Registered office
C-306 Crystal Plaza, Andheri Link Road Andheri(W),
Mumbai,Maharashtra-400053
Ph: 91-22-40682300
E-mail: srane@ankurdrugs.com
URL: http://www.ankurdrugs.com

Quick Links

Advertisement
Quick Links for Ankur Drugs & Pharma

Back to Top